Abstract

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Author(s): Harrington Amy, Williams LaVonn

Issue: Jul/Aug 2022 - Volume 26, Number 4

Page(s): 293-296

Download in electronic PDF format for $75
  • Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Page 1
  • Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Page 2
  • Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Page 3
  • Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Page 4

Abstract

Medications on the market for the treatment of arthritis are more commonly appropriate for adult arthritic patients. However, for patients with juvenile arthritis, a compounding pharmacist can prepare specialized medications for those patients who are in need of a specific dosage, or for those patients who require a different dosage form. Additionally, more than one active ingredient can be combined in pharmacy compounding to meet a specific patient’s needs. Compounded topical/transdermal preparations can provide customized medication options, which may not be commercially available, for pediatric patients with juvenile arthritis.

Related Keywords

  • Amy Harrington
  • juvenile arthritis
  • topical preparations
  • transdermal administration
  • pediatric rheumatic disease
  • autoimmune disorders
  • autoinflammatory diseases
  • inflammation
  • anti-inflammatory agents
  • nonsteroidal anti-inflammatory drugs
  • NSAIDs
  • corticosteroids
  • disease-modifying antirheumatic drugs
  • DMARDs
  • biologic DMARDS
  • tumor necrosis factor inhibitors
  • medication adherence

Related Categories

  • PAIN MANAGEMENT
  • PEDIATRICS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • MUSCULOSKELETAL DISORDERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2022
Pg. 293-296
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Author(s): Harrington Amy, Williams LaVonn
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Mar/Apr 2011
Pg. 124-128
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Author(s): Corsini Lindsay, Williams LaVonn A
Sep/Oct 2013
Pg. 380-383
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
Author(s): McElhiney Linda F
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
Mar/Apr 1997
Pg. 84-86
Compounding for the Pediatric Patient
Author(s): Allen Loyd V Jr
Jan/Feb 2017
Pg. 62
Infliximab 1% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2008
Pg. 498-504
Case Reports: Compounding to Relieve Arthritis Pain
Author(s): Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Nov/Dec 2008
Pg. 476-480
Arthritis Epidemiology Impacts Pharmacists
Author(s): Vance Dwight A
Mar/Apr 2010
Pg. 108-111
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Author(s): Bramwell Bethany L
Sep/Oct 2007
Pg. 384-388
Equine Cushing's Disease: A Clinical Update
Author(s): Bliss George
Jul/Aug 2004
Pg. 277-283
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2
Author(s): Davidson Gigi S
May/Jun 2004
Pg. 169-172
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1
Author(s): Davidson Gigi S
Jul/Aug 2000
Pg. 276-279
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Author(s): Glasnapp Andrew, Schaefer Erin
Jan/Feb 2002
Pg. 16-18
Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh
Author(s): Vail Jane
Sep/Oct 2010
Pg. 382-394
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists
Author(s): Meadows Richard L, Muller George